These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2487508

  • 1. Effects of cilostazol on platelet function.
    Uehara S, Hirayama A.
    Arzneimittelforschung; 1989 Dec; 39(12):1531-4. PubMed ID: 2487508
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease.
    Yasunaga K, Mase K.
    Arzneimittelforschung; 1985 Dec; 35(7A):1186-8. PubMed ID: 4074431
    [Abstract] [Full Text] [Related]

  • 3. Antiaggregatory effect of oral cilostazol and recovery of platelet aggregability in patients with cerebrovascular disease.
    Yasunaga K, Mase K.
    Arzneimittelforschung; 1985 Dec; 35(7A):1189-92. PubMed ID: 4074432
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study.
    Ikeda Y, Kikuchi M, Murakami H, Satoh K, Murata M, Watanabe K, Ando Y.
    Arzneimittelforschung; 1987 May; 37(5):563-6. PubMed ID: 2956957
    [Abstract] [Full Text] [Related]

  • 5. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y, Tani T, Kanbe T, Watanabe K.
    Arzneimittelforschung; 1985 May; 35(7A):1144-9. PubMed ID: 4074426
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring.
    Satoh K, Fukasawa I, Kanemaru K, Yoda S, Kimura Y, Inoue O, Ohta M, Kinouchi H, Ozaki Y.
    Thromb Res; 2012 Oct; 130(4):616-21. PubMed ID: 22728022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S, Yamaguchi S, Katsube T, Kitani M, Okada K, Tsunematsu T.
    Arzneimittelforschung; 1985 Oct; 35(7A):1193-7. PubMed ID: 4074433
    [Abstract] [Full Text] [Related]

  • 10. Effects of forskolin and cilostazol on clot retraction.
    Sannomiya Y, Tatsumi N, Okuda K.
    Biochem Int; 1988 Dec; 17(6):1059-70. PubMed ID: 2854465
    [Abstract] [Full Text] [Related]

  • 11. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS, Taborski U, Szalay Z, Friedel A, Segieth I, Jovin A, Heidinger K, Schreiner K, Frass O, Klövekorn WP, Müller-Berghaus G.
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans.
    Woo SK, Kang WK, Kwon KI.
    Clin Pharmacol Ther; 2002 Apr; 71(4):246-52. PubMed ID: 11956507
    [Abstract] [Full Text] [Related]

  • 14. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH, Hwang JY, Kim IS, Park Y, Hwang SJ, Lee SW, Kwak CH, Park SW.
    Circ Cardiovasc Interv; 2010 Feb 01; 3(1):17-26. PubMed ID: 20118150
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.
    Nakamura T, Uchiyama S, Yamazaki M, Iwata M.
    Thromb Res; 2007 Feb 01; 119(4):511-6. PubMed ID: 17046050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities.
    Kamiya T, Sakaguchi S.
    Arzneimittelforschung; 1985 Feb 01; 35(7A):1201-3. PubMed ID: 4074435
    [Abstract] [Full Text] [Related]

  • 20. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation.
    Kawamura K, Watanabe K, Kimura Y.
    Arzneimittelforschung; 1985 Feb 01; 35(7A):1149-54. PubMed ID: 4074427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.